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ABSTRACT 
Alcoholism is a chronic relapsing disorder and stress is a key precipitant of relapse. 
The nucleus incertus (NI) is highly responsive to corticotrophin releasing factor (CRF) 
and psychological stressors, receives a CRF innervation and expresses CRF1 and 
CRF2 receptor mRNA. Furthermore, the ascending NI relaxin-3 system is implicated 
in alcohol seeking in rats. Therefore, in alcohol-preferring (iP) rats, we examined the 
effect of bilateral injections into the NI of the CRF1 receptor antagonist, CP376395 or 
the CRF2 receptor antagonist, astressin-2B on yohimbine-induced reinstatement of 
alcohol seeking. Using qPCR analysis of NI micropunches we assessed the effects 
of chronic alcohol consumption on gene expression profiles for components of the 
relaxin-3 and CRF systems. Bilateral intra-NI injections of CP376395 (500 ng/0.25 
μL) attenuated yohimbine-induced reinstatement of alcohol seeking. In contrast, 
intra-NI injections of astressin-2B (200 ng/0.25 μL) had no significant effect. In line 
with these data, CRF1, but not CRF2, receptor mRNA was upregulated in the NI 
following chronic ethanol intake. Relaxin family peptide 3 receptor (RXFP3) mRNA 
was also increased in the NI following chronic ethanol. Our qPCR analysis also 
identified CRF mRNA within the rat NI, and the existence of a newly-identified 
population of CRF-containing neurons was subsequently confirmed by detection of 
CRF immunoreactivity in rat and mouse NI. These data suggest NI neurons 
contribute to reinstatement of alcohol seeking, via an involvement of CRF1 signaling. 
Furthermore, chronic ethanol intake leads to neuroadaptive changes in CRF and 
relaxin-3 systems within rat NI. 
 
This article is protected by copyright. All rights reserved.
  
This article is protected by copyright. All rights reserved.
INTRODUCTION  
Alcohol use disorders (AUD) account for approximately 3.8% of deaths and 4.6% of 
disease and injury burden in developed countries (Rhem et al, 2009). Current first 
line pharmacotherapeutics for alcoholism are inadequate, with low compliance, 
adverse side effects and high rates of relapse (Jupp and Lawrence, 2010). Up to 
90% of addicted individuals relapse within 12 months of abstinence (DeJong, 1994), 
most within 3 months (Sinha, 2008). Stress plays a key role in drug/alcohol abuse 
and is a major trigger of relapse (Koob et al, 2014). The neurocircuitry and brain 
chemistry underlying stress and addiction are the subject of ongoing investigation 
(Mantsch et al, 2016), although both involve corticotrophin releasing factor (CRF) 
(Koob et al, 2014). CRF binds to two G-protein-coupled receptors (CRF-receptor 1 
(CRF1) and CRF-receptor 2 (CRF2)), plus CRF binding protein (CRF-BP) (Bale and 
Vale, 2004). CRF is expressed widely throughout the brain and implicated in the 
acquisition, maintenance and relapse of alcohol seeking (Lodge and Lawrence, 
2003; Koob et al, 2014).  
The pontine nucleus incertus (NI) is anatomically divided into the pars compacta 
(NIc) and pars dissipata (NId) (Goto et al, 2001). In rats, the NI was first 
characterized by its dense CRF receptor expression (Potter et al, 1994) and 
sensitivity to exogenous CRF (Bittencourt and Sawchenko, 2000). Afferent and 
efferent connections of the NI suggest it is a likely site of integration for behavioral 
planning and modulation of cognitive processes (Ma et al, 2013). NI neurons are 
predominantly γ-aminobutyric acid (GABA)ergic, and the NI contains the largest 
population of neurons producing the neuropeptide relaxin-3 in rat (Ma et al, 2007), 
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mouse (Smith et al, 2010) and macaque (Ma et al, 2009). The ascending relaxin-
3/RXFP3 (relaxin family peptide 3 receptor) system regulates stress effects on 
alcohol preference in mice (Walker et al, 2015) and reinstatement of alcohol (but not 
sucrose) seeking in rats (Ryan et al, 2013). 
NI relaxin-3 neurons co-express CRF1 receptors (Tanaka et al, 2005; Ma et al, 2013), 
and are activated by psychological stress and intracerebroventricular (icv) CRF 
(Tanaka et al, 2005). Electrophysiological studies confirmed that icv CRF excites 
relaxin-3 neurons within the NI (Ma et al, 2013). Pretreatment with the CRF1 receptor 
antagonist antalarmin attenuated swim-stress induced elevations of relaxin-3 mRNA 
(Banerjee et al, 2010), while CRF depolarization of relaxin-3 NI neurons was 
prevented by NBI35965 (Ma et al, 2013). These data suggest relaxin-3 neurons 
within the NI integrate information related to stressful stimuli in a CRF1-dependent 
manner.  
Chronic alcohol exposure is associated with changes in CRF expression in the 
paraventricular nucleus of the hypothalamus (Rivier et al, 1990), basolateral 
amygdala (BLA) (Falco et al, 2009), and central amygdala (CeA) (Zhou et al, 2013; 
Sommer et al, 2008). In alcohol dependent and certain alcohol-preferring rats CRF 
receptor expression is also altered in the BLA and medial amygdala (Sommer et al, 
2008; Hansson et al, 2006). Given the roles of CRF and relaxin-3 systems in stress-
induced alcohol seeking (Le et al, 2000; Ryan et al, 2013), and the functional 
interaction between CRF and relaxin-3 systems within the NI, we assessed whether 
a CRF receptor-mediated pathway in the NI was implicated in alcohol seeking. We 
also examined the impact of chronic ethanol intake on gene expression within the rat 
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NI.  
MATERIALS AND METHODS  
All studies were performed in accordance with the Prevention of Cruelty to Animals 
Act (2004), under the guidelines of the NHMRC Code of Practice for the Care and 
Use of Animals for Experimental Purposes in Australia (2013) and approved by The 
Florey Animal Ethics Committee. Adult male alcohol-preferring rats (iP) rats were 
obtained from in-house breeding. Parental stock came from Professor T.K. Li (while 
at Indiana University, USA). Rats were pair-housed under ambient conditions (21ºC) 
and maintained on a 12 h light/dark cycle (lights on at 0700h), with access to chow 
and water ad libitum. Post-surgery, rats were single housed. B6(Cg)-
Crhtm1(cre)Zjh/J (Crh-IRES-Cre) mice and B6.Cg-Gt(ROSA)26Sortm14(CAG-
TdTomato)Hze/J; (Ai14) mice were obtained from The Jackson Laboratory (Bar 
Harbor, ME, USA; stock number 012704 and 007914 respectively). Upon arrival, 
mice were backcrossed with a C57BL/6J breeder line, and mutants identified using 
polymerase chain reaction (PCR) procedures provided by the supplier. Homozygous 
Crh-IRES-Cre and Ai14 mice were bred to produce heterozygous Crh-IRES-
CrexAi14 progeny (Cusulin et al, 2013). Mice were housed on a 12 h light/dark cycle 
(lights on at 7:00) with ad libitum access to food and water. 
Alcohol self-administration  
Male iP rats were trained to self-administer ethanol (10% (v/v)) under operant 
conditions using a fixed ratio of 3 (FR3; 3 lever presses for one 100µl reward 
delivery) during 20-min sessions (Lawrence et al, 2006). For each session, total 
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ethanol and water responses were recorded, and the difference in fluid in the ethanol 
reservoir between the beginning and end of the session was recorded to ensure 
correct calibration of the delivery system, and consumption of ethanol. Operant 
conditioning chambers supplied by Med Associates (St Albans, VT, USA) were 
employed. Each chamber was housed individually in sound-attenuation cubicles and 
chambers were connected to a computer running Med-PC IV software (Med 
Associates) to record data. Within the chambers, a house light provided soft 
illumination during operant conditioning sessions. Retractable levers (exerted during 
operant conditioning sessions) were placed below a stimulus light and adjacent to a 
fluid receptacle. Availability of ethanol was conditioned by the presence of an 
olfactory cue (S+; one drop of vanilla essence (Queen Foods, Alderley, QLD, 
Australia) placed directly underneath the ethanol-paired lever of the operant 
conditioning chamber). A 1-s light stimulus (CS+) occurred when the FR3 
requirement was obtained with both the ethanol-paired and water-paired lever. Rats 
underwent an extended period of alcohol self-administration (~7 weeks, 5 
consecutive days per week), followed by surgery.  
Stereotaxic implantation of cannulae into NI 
Rats were anesthetized with isoflurane (5% (v/v) induction, 2% maintenance), 
positioned in a stereotaxic frame (Stoelting Co. Wood Dale, USA), and the scalp 
shaved and cleaned (proviodine-iodine 10% (w/v); Orion Laboratories, Arkles Bay, 
NZ). A small incision was made to expose the skull. Four pits were drilled into the 
skull and screws (1.4 mm diameter and 2 mm length; Mr Specs, Parkdale, Australia) 
inserted. A hole was drilled through the skull and a single stainless steel 26 gauge 
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bilateral cannula cut 7.3 mm below the pedestal (PlasticsOne, Roanoke, USA) was 
implanted relative to bregma: anteroposterior, −9.8 mm; mediolateral, ±0.3 mm; and 
dorsoventral, −7.8 mm, with the incisor bar set at -9.2 mm from the flat skull position 
to flex the head (Paxinos and Watson, 1986). Cannulae were fixed in place using 
dental cement (Vertex-Dental, Zeist, The Netherlands). Patency was maintained by 
inserting a dummy, which projected 1.5 mm beyond the tip (PlasticsOne). Meloxicam 
(3 mg/kg, i.p.) was administered for analgesia, plus antibiotic (Baitryl, 3 mg/kg, i.p.). 
Rats recovered for 7 days. 
Yohimbine-induced reinstatement of alcohol seeking 
After recovery, rats reacquired ethanol responding to pre-surgical levels before 
extinction training. During extinction training no cues were present and there was no 
programmed response following task completion. Extinction sessions continued until 
mean responding on the ethanol-paired lever was <15 lever presses for 3 
consecutive days. Subsequently, rats underwent a yohimbine-induced reinstatement 
session whereby yohimbine (Tocris Bioscience, Bristol, UK) dissolved in distilled 
water was injected (1 mg/kg i.p.) 30 min prior to test (Ryan et al, 2013). During this 
session, rats received intra-NI infusions of either vehicle or treatment directly prior to 
reinstatement testing in a randomized manner. Subsequently rats received 2 days of 
ethanol reacquisition to re-stabilize ethanol consumption and were then re-
extinguished (Lawrence et al, 2006). A second reinstatement test was performed 
where rats received the alternate intra-NI treatment in a counterbalanced manner. 
Cohort 1 (n = 9) received 0.25 μL vehicle and 500 ng/0.25 μL per side of the CRF1 
antagonist CP376395 (Tocris Bioscience), while Cohort 2 (n = 10) received 0.25 μL 
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vehicle and 200 ng/0.25 μL per side of the CRF2 antagonist astressin-2B (Tocris 
Bioscience). Additional rats whose injections fell outside of the NI were used as 
anatomic controls: CP376395 (n = 15) or astressin-2B (n = 7). 
Nucleus incertus infusions 
Bilateral NI infusions were made using 40 cm polyethylene connectors (PlasticsOne) 
attached to 1 μL microsyringes (SGE Analytical Science, Ringwood, Australia). 0.25 
μL of vehicle or drug were infused bilaterally (0.25 μL/min) by an automated syringe 
pump (Harvard Apparatus, Holliston, USA). The injectors were left in place for 2 min 
after infusion. After completion of behavioral testing, rats were anesthetized with 
pentobarbitone (100 mg/kg i.p., Virbac, Milperra, Australia). Correct cannula 
positioning was verified in each rat by infusing methylene blue (0.25 μL/side). Rats 
were euthanized (pentobarbitone (100 mg/kg i.p.)), brains collected, frozen over 
liquid nitrogen and sectioned for injection site validations, which were performed by 
an investigator blinded to the identity of the tissue.  
Drugs  
CP376359 and astressin-2B were purchased from Tocris Bioscience and dissolved 
in normal saline (0.9% NaCl). The dose of CP376395 was selected based on 
previous studies, which showed microinjections into the rat VTA to attenuate cocaine 
seeking, without inducing any non-specific motor impairments (Blacktop et al, 2011). 
The dose of astressin-2B was chosen based on previous studies (Tran et al, 2014).  
Two-bottle free-choice drinking 
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A separate cohort (n = 21) of individually housed male iP rats were acclimatized to 
drinking from two bottles of tap water. 14 rats then had one bottle replaced with 
ethanol (10% v/v), while the remaining n = 7 rats received tap water only. Over the 
subsequent ~125 days, fluid consumption volumes were calculated daily between 
0930 and 1100 h. The position of bottles was altered randomly. Ethanol was 
removed 24 h prior to culling to avoid acute pharmacological effects of ethanol on 
mRNA. Rats were anesthetized with pentobarbitone (100 mg/kg i.p.) decapitated and 
the brains rapidly dissected and frozen over liquid nitrogen (-80 °C). 
 
Tissue preparation and qPCR 
NI bilateral micro-punch samples (diameter: 0.3 mm, thickness: 400 µm) were taken 
relative to bregma: anteroposterior, −9.72 mm; mediolateral, ±0.3 mm; and 
dorsoventral, -7.6 mm (Paxinos and Watson, 1986) over dry ice using micro-
dissection needles (ProSciTech, Kirwan, Australia). Micropunches were 
homogenized using QIAzol Lysis Reagent (Qiagen, Venlo, The Netherlands) and 
RNA purified using the RNeasy Micro Kit (Qiagen). RNA yields, concentration and 
purity were measured using a Nanodrop 2000C UV-Vis Spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA). For each sample, 0.3 µg of total RNA was reverse 
transcribed into cDNA using TaqMan Reverse Transcription reagents (Thermo Fisher 
Scientific) with random hexamers. Reverse transcription was performed on a 2720 
Thermal Cycler (Applied Biosystems, Foster City, USA): 10 min at 25°C, 30 min at 
42°C, 5 min at 95°C and hold at 4°C. cDNA products were stored at -20°C until use. 
See Table 1 for primer sequences.  
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qPCR was performed on a ViiATM 7 Real Time PCR System (Applied Biosystems). 
Reactions were performed in triplicate in optical 384-well plates (Applied 
Biosystems): 10 min at 95°C for polymerase activation followed by 40 cycles of 15 
sec at 95°C and 1 min at 60°C. Each reaction contained 2 µL of cDNA, 5 µL of 
Power SYBR Green PCR Master Mix (Thermo Fisher Scientific), sense and 
antisense primers (0.5 µL, each 20 µM) made up to 10 µL with DEPC water. Data 
were analysed using 7500 Fast System Sequence Detection Software. Expression 
levels of mRNA transcripts encoding relaxin-3 (Rln3), RXFP3 (Rxfp3), CRF1 (Crhr1), 
CRF2 (Crhr2), CRF-binding protein (Crhbp), and CRF (Crh) were assessed. Target 
gene expression was normalized to the expression of the internal control gene 
encoding GAPDH (Gapdh) using the 2-ΔΔCT method as described (Scmittgen et al, 
2008), and mean relative gene expression calculated for each target. 
iP rat immunohistochemistry 
Ethanol naïve adult male iP rats (350 g; n = 2) were anaesthetized with isoflurane 
(5% induction, 2% maintenance) and placed into a stereotaxic frame (Stoelting Co.). 
80 μg colchicine (Sigma-Aldrich, Schnelldorf, Germany) dissolved in 5 μL of 0.9% 
NaCl was injected into the lateral ventricle (anteroposterior, −0.9 mm; mediolateral, -
1.3 mm; and dorsoventral, −3.8 mm from bregma) via a needle connected to a 10 μL 
Hamilton syringe (Harvard Apparatus). Meloxicam (3 mg/kg, i.p.) was administered 
for analgesia. After 24 h rats were deeply anaesthetized with pentobarbitone (100 mg 
kg; i.p.) and transcardially perfused with 400 ml of 0.1 M phosphate buffered saline 
(PBS; 137 mM NaCl, 2.7 KCl, 11.2 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) followed 
by 500 ml of 1% paraformaldehyde (PFA; Sigma-Aldrich) with 15% (v/v) picric acid 
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(Sigma-Aldrich) (Gunn et al, 2013) in PBS. Rats were then decapitated, brains 
removed and submerged in fixation solution for 24 h at 4◦C. Brains were then 
transferred to 20% (w/v) sucrose in PBS for 24 h at 4◦C. Coronal sections (50 μm) 
through the NI were cut on a cryostat at −18◦C (Cryocut 1800; Leica Microsystems, 
Heerbrugg, Switzerland) and collected into PBS.  
Sections were preincubated (10% v/v normal goat serum (NGS) in PBS containing 
0.5% TritonX-100) for 1 h at room temperature (RT). Sections were then incubated in 
a primary antibody mix of 1:2000 dilution rabbit anti-CRF (PBL#C70) (Sawchenko et 
al, 1984) and 1:5 dilution mouse monoclonal anti-Relaxin-3 (HK4–144–10) (Tanaka 
et al, 2005), with 2% NGS in PBS containing 0.1% TritonX-100 for 48 h at 4◦C. 
Sections were washed 3 × 5 min in PBS and incubated in biotinylated donkey anti-
rabbit IgG (1:500, Vector Laboratories, Burlingame, USA, BA-1000) for 2h. Following 
3 × 5 min washes in PBS, sections were incubated in avidin–biotin complex (ABC; 
VectaStain Elite; Vector Laboratories), followed by 3 × 5 min washes in PBS and 2 h 
incubation in a mix of 1:400 dilution donkey anti-mouse-Alexa488 secondary 
antibody (Life Technologies, Carlsbad, USA, A-21202) and streptavidin-Alexa594 
(Life Technologies, S-11227).  
Crh-IRES-CrexAi14 mouse immunohistochemistry 
Mice (9 weeks, n = 2) were anaesthetized (pentobarbitone, 80 mg kg; i.p.) and 
transcardially perfused with 50 ml of 0.1 M PBS followed by 50 ml of 4% PFA in PBS. 
Mice were then decapitated, brains removed and submerged in PFA for 1 h at 4◦C. 
Brains were then transferred to 20% (w/v) sucrose in PBS for 24 h at 4◦C. Coronal 
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sections (40 μm) through the NI were cut on a cryostat at −18◦C (Cryocut 1800; 
Leica Microsystems) and collected into PBS. Sections were pre-blocked (10% v/v 
normal goat serum (NGS) in PBS containing 0.5% TritonX-100) for 1 h at RT. 
Sections were then incubated with rabbit anti-DsRed (1:2000, Clonetech, 632496) 
(Krashes et al, 2011) and mouse monoclonal anti-Relaxin-3 (1:5) (HK4–144–10) 
(Tanaka et al, 2005) with 2% NGS in PBS containing 0.1% TritonX-100 overnight at 
RT. Sections were washed 3 × 5 min in PBS and incubated in donkey anti-mouse-
Alexa488 (1:400, Life Technologies, Carlsbad, USA, A-21202) and donkey anti-
rabbit-Alexa594 (1:400, Life Technologies, A-21207) for 2 h at RT.  
Sections were washed 3 × 5 min, mounted on glass microscope slides with 
fluorescence mounting medium (DAKO, Carpentaria, USA). Micrographs were 
obtained using a confocal microscope (Leica DM LB2, Leica Microsystems). 
Statistical analysis 
Behavioral data were analyzed by repeated measures (RM) two-way ANOVA with 
Bonferroni post hoc analysis using the statistical software SPSS  (Version 21; IBM 
Corp., Armonk, NY, USA). GraphPad Prism (Version 5; GraphPad Software, Inc., La 
Jolla, CA, USA) was used for t-test statistical comparisons of qPCR data and to 
generate graphs. Data are reported as mean ± SEM, significance set at p < 0.05. 
EXT data are reported as an average of the last 3 days before reinstatement test. 
RESULTS 
Ethanol self-administration 
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During the last week of ethanol (10%v/v) self-administration rats averaged 90 ± 5.3 
ethanol-paired lever presses (0.56 ± 0.3 g/kg/session ethanol intake), and 6.3 ± 0.3 
water-paired lever presses (0.02 ± 0.003 g/kg/session water intake) which results in 
pharmacologically relevant blood alcohol levels (Roberts et al., 1999). 
Nucleus incertus CRF1 receptor antagonism attenuates yohimbine-induced 
reinstatement of alcohol seeking 
We investigated the effect of the CRF1 receptor antagonist, CP376395 on yohimbine-
induced reinstatement of alcohol seeking in rats. RM two-way ANOVA revealed a 
significant main effect of both treatment (F(2,7) = 21.925, p < 0.001) and lever (F(1,8) = 
41.261, p < 0.001) and a significant treatment x lever interaction (F(2,8) = 23.165, p < 
0.001). Bonferroni post hoc analysis showed yohimbine to induce a robust 
reinstatement of alcohol seeking in vehicle-treated animals (EXT vs. VEH, p < 0.001; 
Fig 1B), while CP376395 injected directly into the NI significantly reduced this 
reinstatement of alcohol seeking (VEH vs. CP376395, p = 0.036; Fig 1A). No 
differences in latency to ethanol reward were observed between VEH and 
CP376395-treated rats (Student’s t-test; p = 0.356). Time course data revealed a 
significant decrease in responding from 5 - 10 min during the reinstatement test (RM 
two-way ANOVA; p < 0.001; Fig 1C)  
To assess anatomic specificity injections were made immediately adjacent to the NI 
and/or within the fourth ventricle (4V) as controls. RM two-way ANOVA revealed an 
overall effect of both treatment (F(2,13) = 39.194, p < 0.001) and lever (F(1,14) = 
111.858, p < 0.001) and a significant treatment x lever interaction (F(2,13) = 39.562, p 
< 0.001). Bonferroni post hoc analysis confirmed yohimbine administration induced 
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reinstatement of alcohol seeking in vehicle-treated rats (EXT vs. VEH, p < 0.001; Fig. 
1B). However, CP376395 control injections had no effect on yohimbine-induced 
reinstatement of alcohol seeking (p = 0.218; Fig. 1B), suggesting a localized effect 
within the NI. Injection sites were validated histologically for all CP376395-treated 
rats (Fig. 1D). 
Nucleus incertus CRF2 receptor antagonism does not attenuate yohimbine-
induced reinstatement of alcohol seeking 
We also investigated the effect of the CRF2 receptor antagonist, astressin-2B, on 
yohimbine-induced reinstatement of alcohol seeking. RM two-way ANOVA revealed 
a significant main effect of both treatment (F(2,8) = 44.510, p < 0.001) and lever (F(1,9) 
= 138.703, p < 0.001) and a significant treatment x lever interaction (F(2,8) = 44.010, p 
< 0.001). Bonferroni post hoc analysis showed yohimbine to induce a robust 
reinstatement of alcohol seeking in vehicle-treated rats (EXT vs. VEH, p < 0.001; Fig 
2A), however astressin-2B injected directly into the NI had no effect on reinstatement 
of alcohol seeking (VEH vs. astressin-2B, p = 0.177; Fig 2A). No difference in latency 
to reward was observed between astressin-2B and VEH-treated animals (Student’s t-
test; p = 0.250). There were no time course differences during reinstatement (Fig 
2C). 
Anatomic specificity was also tested for astressin-2B, with injections made 
immediately adjacent to the NI as controls. RM two-way ANOVA revealed an overall 
effect of both treatment (F(2,5) = 37.934, p < 0.001) and lever (F(1,6) = 86.049, p < 
0.001)and a significant treatment x lever interaction (F(2,5) = 26.453, p < 0.001). Once 
again, Bonferroni post hoc analysis showed yohimbine administration induced 
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reinstatement of alcohol seeking in vehicle-treated rats (EXT Vs. VEH, p < 0.001; 
Fig. 2B). However, astressin-2B control injections had no effect on yohimbine-
induced reinstatement of alcohol seeking (p = 0.218; Fig. 1B). Injection sites were 
validated histologically for all astressin-2B-treated rats (Fig. 2D). 
Chronic alcohol consumption increases CRF1 and RXFP3 receptor expression 
within the nucleus incertus 
To assess changes in CRF and relaxin-3 system-related gene expression within the 
NI, male adult iP rats were provided a choice between either water and 10% ethanol, 
or water alone, for ~125 days. After an initial ~25 day period in which rats with 
access to alcohol displayed escalating rates of consumption and preference, over the 
remaining ~100 days consumption remained stable. During the last week of ethanol 
consumption rats averaged 4.1 ± 0.5 g/kg/day ethanol intake, with an alcohol 
preference of 79.2 ± 5.3% (Fig. 3). 
Rats were culled and tissue that encompassed the NI was collected (Fig. 4A) for 
qPCR analysis. Importantly, high levels of relaxin-3 mRNA were detected within 
every individual tissue sample, confirming correct tissue targeting. Chronic ethanol 
consumption did not alter relaxin-3 expression, relative to water controls (Student’s t-
test; p = 0.414; Fig. 4B). Expression of mRNA encoding the cognate receptor for 
relaxin-3, RXFP3, was significantly increased in rats following long-term voluntary 
ethanol intake compared to water controls (Student’s t-test; p = 0.012; Fig. 4C). CRF1 
receptor gene expression was significantly increased following chronic ethanol intake 
(Student’s t-test; p = 0.037; Fig. 4D). In contrast, no changes in the expression of 
mRNA encoding CRF2 receptors or CRF-BP were observed (Student’s t-test; p = 
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0.704 and p = 0.394; Fig. 4E and 4F). CRF mRNA was detected within the NI but not 
altered by chronic ethanol intake (Student’s t-test; p = 0.114; Fig. 4G). 
A population of CRF-positive neurons within the NI 
To confirm the presence of CRF-containing neurons within the NI, we employed 
immunohistochemistry with a validated CRF antibody (Sawchenko et al, 1984) and 
Crh-IRES-CrexAi14 transgenic mice (Cusulin et al, 2013). Barrington’s nucleus was 
included as a positive control for CRF-like-IR specificity. A high density of cells 
displaying CRF-like-IR was evident within Barrington’s nucleus, however CRF-like-
IR-positive soma were largely absent in adjacent regions concordant with previous 
reports (Swanson et al, 1983; Fig. 6A, 7A). Importantly however, cell soma with 
punctate cytoplasmic CRF-like-IR were observed throughout the rostrocaudal axis of 
the iP rat and the Crh-IRES-CrexAi14 mouse NI (Table 2, 3; Fig. 5, 6, 7; CRF-like IR 
red circles; relaxin-3-like IR green circles), which was identified via double-labeling 
with relaxin-3 (Tanaka et al, 2005; Ma et al, 2013). While a small number of CRF-
positive neurons co-express relaxin-3 (Table 2, 3; Fig. 6, 7), the majority do not 
(Table 2, 3; Fig. 6, 7). CRF-positive cells were distributed throughout both the pars 
compacta and dissipata regions of the NI and more numerous towards the caudal 
extent of the NI (Table 2, 3).  
 
DISCUSSION 
Our results demonstrate that CRF1 receptor antagonism in the NI via local 
microinjection of CP376395 attenuates yohimbine-induced reinstatement of alcohol 
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seeking in iP rats. Importantly, injections of the same dose of CP376395 immediately 
adjacent to the NI had no effect, suggesting the effect is specifically associated with 
actions on NI neurons and not CRF1-positive neurons in adjacent areas. In contrast, 
intra-NI injections of astressin-2B did not alter alcohol seeking at the dose employed, 
suggesting a lesser role for CRF2 signaling within the NI in the regulation of this 
behavior, despite CRF2 expression within this region. Importantly, the attenuation of 
alcohol seeking after intra-NI CP376395 confirms that under our experimental 
paradigm, CRF is released within the NI and contributes to the observed behavior.  
Our findings are in accordance with immunohistochemical, electrophysiological and 
behavioral studies that demonstrate CRF and/or stress act via CRF1 to activate 
relaxin-3 containing neurons within the NI (Tanaka et al, 2005; Banerjee et al, 2010; 
Ma et al, 2013). In combination with previous studies which demonstrated that 
relaxin-3/RXFP3 signaling within the BNST promotes yohimbine-induced alcohol 
seeking (Ryan et al, 2013), our data are consistent with the hypothesis that stress 
activates CRF input(s) to the NI, which acts upon CRF1 receptors to drive ascending 
relaxin-3 pathways innervating the BNST (and likely other stress-relapse circuitry) to 
contribute to reinstatement of alcohol seeking. It is important to note that intra-NI 
CP376395 attenuated but did not prevent yohimbine-induced reinstatement of 
alcohol seeking. This is to be expected given the complex circuitry and multiple 
neurotransmitters/neuropeptides known to contribute to stress-induced alcohol 
seeking (Mantsch et al 2016). Nevertheless, our findings suggest that CRF1 receptor 
signaling within the NI is involved in this process, and that the NI therefore apparently 
interfaces with the established stress-relapse circuitry. In this regard, the BNST is a 
likely candidate where ascending relaxin-3 neurons modulate relapse-like behavior 
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(Ryan et al., 2013). 
The exact mechanisms involved in yohimbine-induced reinstatement of operant 
responding still require elucidation. A recent study showed that yohimbine reinstates 
lever pressing in rats that were previously trained with lever pressing resulting in cue 
presentation with or without reward delivery and therefore may not necessarily act as 
a stressor model (Chen et al, 2015). It is however noteworthy that yohimbine-induced 
reinstatement of ethanol seeking can be prevented by treatments that do not impact 
upon yohimbine-induced reinstatement of sucrose seeking (Ryan et al., 2013), 
suggesting that cue reactivity is not the only factor behind a yohimbine-induced 
reinstatement of reward seeking. Importantly, yohimbine induces anxiety and the 
subjective measures of alcohol intoxication in healthy humans (McDougle et al, 
1995), as well as craving in human alcoholics (Umhau et al., 2011) and opiate 
addicts (Greenwald et al, 2013). Based on this property yohimbine has been 
suggested to represent an ideal cross-species probe for translational addiction 
research (See & Waters, 2010). Yohimbine produces a robust and stable 
reinstatement of alcohol seeking in rats (Le et al, 2000). Importantly in the context of 
the present study, yohimbine shares a commonality with footshock stress-induced 
reinstatement of alcohol seeking in that both are critically dependent upon 
extrahypothalamic CRF1 receptor signaling (Marinelli et al., 2007). Moreover, 
yohimbine administration also induces c-fos and CRF mRNA in limbic regions to a 
similar degree as foot-shock (Funk et al, 2006). Therefore, while yohimbine may act 
via more than one mechanism to precipitate reinstatement of alcohol seeking it is 
nevertheless a useful tool to assess the involvement of CRF1 receptors in 
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reinstatement following extinction. Note also that yohimbine specifically reinstated 
responding on the lever associated with alcohol and not the lever paired with water.  
CRF1 antagonists effectively attenuate both footshock- and yohimbine- induced 
reinstatement of alcohol seeking (Le et al, 2000; Marinelli et al, 2007). Interestingly, 
existing evidence suggests that CRF1 antagonists are more effective in attenuating 
stress-induced reinstatement in rats with increased stress sensitivity, such as post-
dependent rats or behaviorally selected lines that prefer alcohol (Hansson et al, 
2006; Gehlert et al, 2007). It has been proposed that this behavior may be mediated 
by the upregulation of CRF1 receptor gene expression. For example Marchigian 
Sardinian alcohol-preferring (msP) rats display increased CRF1 receptor mRNA 
expression in limbic regions compared with Wistar rats, and unlike non-dependent 
Wistar rats, msP rats are susceptible to attenuation of drinking after treatment with a 
CRF1 receptor antagonist (Hansson et al, 2006). Consistent with this theory, iP rats 
also have enhanced CRF/stress responsivity (Ehler et al, 1992).  
Our molecular data demonstrate that CRF1, but not CRF2, receptor gene expression 
was upregulated within the NI following chronic voluntary ethanol consumption and 
confirms that chronic ethanol intake modulates expression of CRF system 
components within the rat NI. Our findings also provide further support that CRF1 and 
CRF2 receptors may have differential roles with regards alcohol intake/seeking. For 
example, administration of a CRF1 receptor antagonist, CP154546, or the CRF2 
receptor agonist, urocortin 3, dose-dependently reduced binge-like ethanol intake in 
C57BL/6J mice (Lowery et al, 2010). In addition, urocortin 3 reduces stress-related 
behavior and ethanol self-administration in ethanol-dependent rats following acute 
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withdrawal (Valdez et al, 2004). Chronic intermittent ethanol exposure in mice 
upregulates CRF1, but not CRF2, receptor transcripts in the CeA (Eisenhardt et al, 
2015). In line with this, we did not detect changes in CRF2 receptor mRNA 
expression within the NI following chronic ethanol consumption; however, the mRNA 
encoding CRF1 receptors was upregulated. Given our behavioral data, it is possible 
that increased CRF1 receptor expression within the NI may contribute to a 
heightened CRF/stress response, leaving rats more susceptible to reinstate. 
However methodological differences must be considered. Different drinking 
paradigms were employed when examining the role of CRF receptors in operant 
behavior compared to mRNA regulation following long-term voluntary ethanol 
consumption. Our operant studies were designed to model relapse-like behavior and 
examine the role of CRF1 receptor signaling within the NI in this regard. On the other 
hand, our chronic ethanol consumption model was designed to assess whether 
molecular adaptations to relaxin-3 and/or CRF systems occurred within the NI after 
long-term intake. Both of these paradigms model features of human AUD and 
therefore are different, but also complementary, means to study alcohol-related 
problems. Therefore, the fact that intra-NI CRF1 receptor antagonism behaviorally 
reduced alcohol seeking while chronic ethanol consumption regulated CRF1 receptor 
mRNA expression within the NI provides strong support for a role of NI CRF 
signaling in aspects of alcohol use and abuse.   
The NIc and NId receive innervation from similar afferent sources, including the 
medial prefrontal cortex, lateral hypothalamus, lateral habenula and BNST (Goto et 
al, 2001), plus a recently revealed CRF input from the lateral preoptic area (Ma et al, 
2013). Previous studies evaluating CRF distribution in the brainstem have shown 
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scattered CRF-like-IR (Sutin and Jacobowitz, 1988). Our identification of CRF-
positive neurons and fibers within the rat and mouse NI suggests both extrinsic and 
intrinsic sources of CRF apparently exist in this nucleus.  
RXFP3 mRNA was significantly upregulated within the NI following chronic voluntary 
ethanol consumption. While RXFP3 may act as an autoreceptor on NI neurons, it is 
also possible that RXFP3 is expressed by adjacent neurons that receive relaxin-3 
inputs. In contrast, relaxin-3 expression was unaltered by chronic alcohol 
consumption, which corroborates our previous study in which relaxin-3 expression 
(detected via in situ hybridization) was unaltered by chronic alcohol consumption in 
iP rat brain (Ryan et al. 2014). Notably relaxin-3 expression in the NI of iP rats 
correlated with alcohol consumption, suggesting that natural variations in expression 
may relate to the propensity to consume alcohol (Ryan et al. 2014).  
CRF is implicated in stress-induced reinstatement acting in extrahypothalamic 
regions, including the ventral tegmental area (VTA) (Blacktop et al, 2011; Chen et al, 
2014) and ventral BNST (Erb and Stewart, 1999); and in specific projections from the 
CeA to the BNST (Erb et al, 2001), and the BNST to the VTA (Silberman et al, 2013). 
The NI sends relaxin-3 containing efferent projections to all of these regions, and in 
particular, relaxin-3/RXFP3 signaling within the BNST promotes yohimbine-induced 
alcohol seeking (Ryan et al, 2013). The present studies reveal that CRF1 receptor 
signaling within the NI is implicated in yohimbine-induced alcohol seeking, while 
chronic alcohol consumption increases RXFP3 and CRF1 receptor expression within 
the NI. Furthermore, we reveal for the first time the existence of a population of CRF-
positive neurons within the NI. Taken together, these findings give further credence 
This article is protected by copyright. All rights reserved.
to the hypothesis that the NI/relaxin-3 system functionally interfaces with CRF/CRF1 
signaling to modulate stress-associated responses, including alcohol seeking.  
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Figure Legends 
 
Figure 1. Bilateral injections of CRF1 antagonist CP376395 into the nucleus 
incertus attenuated yohimbine-induced reinstatement of alcohol seeking. (A) 
Ethanol-paired lever and water-paired lever presses following bilateral NI injections 
of CRF1 antagonist CP376395 (n = 9). (B) Ethanol-paired lever and water-paired 
lever presses in anatomic controls for CP376395 infusion (n = 15). (C) Time course 
of lever pressing throughout reinstatement session for vehicle (V) or CP376395. (D) 
Neuroanatomical representation of injection sites for CP376395 treated rats. Green 
circles represent NI injections, red triangles represent anatomic controls. Data were 
analyzed by repeated measures two-way ANOVA with post-hoc Bonferroni multiple 
comparisons test and expressed as mean ± SEM. Extinguished rats (EXT), and rats 
that underwent yohimbine-induced reinstatement, pre-treated with either, vehicle (V) 
or 500 ng CP376395 (CP). EXT data are represented as combined values of the last 
3 days of EXT prior to each reinstatement test. Yohimbine precipitated reinstatement 
of alcohol seeking (***p < 0.001), which was attenuated by CP76395 microinjection 
within the NI (#p < 0.05). Furthermore time course data revealed a significant 
difference in responding 5 - 10 min into the reinstatement test (***p < 0.001). 
 
Figure 2. Bilateral injections of CRF2 antagonist astressin-2B into the nucleus 
incertus does not attenuate yohimbine-induced reinstatement of alcohol 
seeking. (A) Ethanol-paired lever and water-paired lever presses following bilateral 
NI injections of CRF-R2 antagonist astressin-2B (n = 10).  (B) Ethanol-paired lever 
and water-paired lever of anatomic controls following astressin-2B infusion (n = 7). 
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(C) Time course of lever pressing throughout reinstatement session for vehicle (V) or 
astressin-2B. (D) Neuroanatomical representation of injection sites for astressin-2B 
treated rats. Green circles represent NI injections, red triangles represent anatomic 
controls. Data were analysed by repeated measures two-way ANOVA with post-hoc 
Bonferroni multiple comparisons test and expressed as mean ± SEM. Extinguished 
rats (EXT), and rats that underwent yohimbine-induced reinstatement, pre-treated 
with either, vehicle (V) or 200 ng astressin-2B (A2B). EXT data are represented as 
combined values of the last 3 days of EXT prior to each reinstatement test. 
Yohimbine induced reinstatement of alcohol seeking (***p < 0.001), astressin-2B did 
not attenuate this behaviour; no differences in time course data were observed. 
 
Figure 3. Two bottle choice fluid and ethanol consumption in iP rats. (A) 
Ethanol intake relative to body weight for ethanol-consuming iP rats (g/kg/day) and 
(B) 10% ethanol solution preference. All values are mean ± SEM, n = 14. 
Abbreviations: EtOH, ethanol. 
 
Figure 4. Chronic ethanol intake modulates the expression of components of 
the relaxin-3 and CRF system in the iP rat NI. (A) Representative micropunch 
dissection of the NI. Relative mRNA expression of (B) relaxin-3, (C) RXFP3, (D) 
CRF1, (E) CRF2, (F) CRF-BP and (G) CRF in rats voluntarily administering water (n = 
7) or ethanol (n = 14) for >125 days. Data were analyzed by unpaired student’s t-test 
and expressed as mean ± SEM. Chronic alcohol consumption increased RXFP3 and 
CRF1 receptor mRNA in the NI (*p < 0.05). Abbreviations: Cb, cerebellum; NI, 
nucleus incertus; 4V, fourth ventricle, CG, central gray. 
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Figure 5. CRF is expressed throughout the rat nucleus incertus. Schematic 
representation of CRF expression through the rostrocaudal axis of the rat nucleus 
incertus. Relaxin-3 positive neurons indicated in green, CRF positive neurons 
indicated in red. Distance from bregma is indicated for each section. Abbreviations: 
4V, fourth ventricle; Cb, cerebellum; PDTg, posterodorsal tegmental nucleus. 
 
Figure 6. CRF positive neurons are present within the nucleus incertus of the 
iP rat. (A) Low magnification confocal projection image of a section illustrating CRF 
positive neurons within the nucleus incertus and adjacent Barrington's nucleus of the 
iP rat. Overview of CRF positive neurons within the (B) NI compacta (NIc) and (C) NI 
dissipata (NId). Confocal projection of (D) CRF, (E) relaxin-3, and (F) overlay show 
both CRF positive/relaxin-3 negative cells and CRF negative/relaxin-3 positive cells. 
High magnification confocal projection of (G) CRF, (H) relaxin-3, and (I) overlay 
showing co-localization of CRF and relaxin-3. Relaxin-3 neurons (green) and CRF 
neurons (red), co-localisation indicated by arrowhead, while CRF positive / relaxin-3 
negative neurons indicated by arrow. 4V, fourth ventricle; NIc, nucleus incertus 
compacta; NId, nucleus incertus dissipata; Bar, Barrington’s nucleus; PDTg, 
posterodorsal tegmental nucleus.  
 
Figure 7. CRF positive neurons are present within the nucleus incertus of the 
Crh-IRES-CrexAi14 mouse. (A) Low magnification confocal projection image 
illustrating CRF/TdT positive neurons within the NI and Barrington’s nucleus of Crh-
IRES-CrexAi14 mice. Overview of CRF positive neurons within the (B) NI compacta 
This article is protected by copyright. All rights reserved.
(NIc) and (C) NI dissipata (NId) of Crh-IRES-CrexAi14 mice. High magnification 
confocal projection of CRF/TdT (D), relaxin-3 (E), and overlay (F), showing co-
localization of CRF/TdT and relaxin-3 within the NIc of the Crh-IRES-CrexAi14 
mouse. Relaxin-3 neurons (green) and CRF/TdT neurons (red), co-localisation 
indicated by arrowhead, while CRF positive / relaxin-3 negative neurons indicated by 
arrow. Abbreviations: TdT, TdTomato; NIc, nucleus incertus compacta; NId, nucleus 
incertus dissipata; Bar, Barrington’s nucleus; PDTg, posterodorsal tegmental 
nucleus. 
 






Forward primer 5’-CCCTATGGGGTGAAGCTCTG-3’ 
Reverse primer 5’-GCTTCTCCATCAGCGAAGAA-3’ 
RXFP3 
 
Forward primer 5’-AGGCCAGGGTACGGATCCT-3’ 
Reverse primer 5’-CCAGTCCCAGGGCACAAAC-3’ 
CRF Forward primer 5’-AAATGGCCAGGGCAGAGCAGT-3’ 
Reverse primer 5’-TGGCCAAGCGCAACATTTCAT-3’ 
CRF1 Forward primer 5’- TGCCAGGAGATTCTCAACGAA-3’ 
Reverse primer 5’- AAAGCCGAGATGAGGTTCCAG-3’ 
CRF2 Forward primer 5’-CTCATCAATTTTGTGTTTCTGTTCAA-3’ 
Reverse primer 5’-CTGTACTGGATGGTCTCGGATGT-3’ 
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CRF-BP Forward primer 5’-GCCCAGTGAGTTCTCCACAGTT-3’ 
Reverse primer 5’-CATGTGTGCAGGTTTTCAAAGC-3’ 
GAPDH Forward primer 5'-CTACCCCCAATGTATCCGTTG-3' 
 Reverse primer 5'-AGCCCAGGATGCCCTTTAGT-3’ 
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Table 2. Number of corticotrophin releasing factor (CRF) positive neurons 
throughout the rostrocaudal axis of the iP rat nucleus incertus. Numbers shown 
as an average across two ethanol naïve iP rats. Sections cut at 50 µm in a 1 in 2 
series from -9.30 mm to -10.0 mm relative to bregma. Abbreviations: NIc, nucleus 
incertus compacta; NId, nucleus incertus dissipata; CRF, corticotrophin releasing 





(bregma) NIc NId Total 
 CRF CRF/RLX3 CRF CRF/RLX3 CRF CRF/RLX3 
- 9.3 mm 1.5 0.5 1.5 0 3 0.5 
- 9.4 mm 3 0 3 0 6 0 
- 9.5 mm 3.5 0 8.5 0 12 0 
- 9.6 mm 2 0 6.5 0 8.5 0 
- 9.7 mm 4.5 0.5 8 0 12.5 0.5 
- 9.8 mm 9.5 0 10.5 0 20 0 
- 9.9 mm 6.5 1 4 0 10.5 1 
- 10.0 mm 4 0 6.5 0 10.5 0 
Total 34.5 2 48.5 0 83 2 
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Table 3. Number of corticotrophin releasing factor (CRF) positive neurons 
throughout the rostrocaudal axis of the Crh-IRES-Cre+/−;Ai14+/− mouse 
nucleus incertus. Numbers shown as an average across two ethanol naïve Crh-
IRES-Cre+/−xAi14+/− mice. Sections cut at 40 µm from 5.4 mm to 5.6 mm relative to 
bregma. Abbreviations: NIc, nucleus incertus compacta; NId, nucleus incertus 




(bregma) NIc NId Total 





-  5.40 mm 16.5 0.5 8.5 
0 
25 0.5 





-  5.48 mm 18 0 12.5 
0 
30.5 0 
- 5.52 mm 20 1 13.5 
0 
33.5 1 
- 5.56 mm 19.5 0 11 
0 
30.5 0 
- 5.60 mm 19 0 18 
0 
37 0 
Total 110.5 2.5 75 0 184.5 2.5 
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